(en) Takafumi Sato et Kenji Yamawaki, « Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin », Clinical Infectious Diseases, vol. 69, no Suppl. 7, , S538–S543 (DOI10.1093/cid/ciz826, lire en ligne, consulté le ).
(en) A .Ito, T. Nishikawa, S. Matsumoto, H. Yoshizawa, T. Sato, R. Nakamura, M. Tsuji, Y. Yamano, « Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa », Antimicrobial Agents and Chemotherapy, vol. 60, no 12, , p. 7396–7401 (PMID27736756, PMCID5119021, DOI10.1128/AAC.01405-16, lire en ligne, consulté le )
nih.gov
ncbi.nlm.nih.gov
(en) Takafumi Sato et Kenji Yamawaki, « Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin », Clinical Infectious Diseases, vol. 69, no Suppl. 7, , S538–S543 (DOI10.1093/cid/ciz826, lire en ligne, consulté le ).
(en) A .Ito, T. Nishikawa, S. Matsumoto, H. Yoshizawa, T. Sato, R. Nakamura, M. Tsuji, Y. Yamano, « Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa », Antimicrobial Agents and Chemotherapy, vol. 60, no 12, , p. 7396–7401 (PMID27736756, PMCID5119021, DOI10.1128/AAC.01405-16, lire en ligne, consulté le )
